Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease ; volume:12 ; number:1 ; day:8 ; month:9 ; year:2022 ; pages:1-22 ; date:12.2022
Scientific reports ; 12, Heft 1 (8.9.2022), 1-22, 12.2022

Creator: Pourtaher, Hormoz
Hasaninejad, Alireza
Iraji, Aida

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-022-18224-6

URN: urn:nbn:de:101:1-2022112521094310338908

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pourtaher, Hormoz
Hasaninejad, Alireza
Iraji, Aida
SpringerLink (Online service)

Other Objects (12)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Related objects

Reset password